Results 1 to 10 of about 17,375 (206)

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks [PDF]

open access: yesInternational Journal of Preventive Medicine, 2023
Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour   +5 more
doaj   +2 more sources

Prevalence of antiphospholipid syndrome among women with recurrent pregnancy loss: a cohort study [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
Objective: This study aimed to evaluate the prevalence of antiphospholipid syndrome (APS) among women experiencing recurrent pregnancy loss (RPL). Methods: A cross-sectional was conducted, reviewing the medical records of 134 women with a history of two
Elaine Cristina Fontes de Oliveira   +3 more
doaj   +2 more sources

Anticardiolipin antibodies and severe leptospirosis [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2003
Laurent RODA
doaj   +5 more sources

Evaluation of Serum Anticardiolipin Antibodies and D-dimer in Recipients of COVID-19 Vaccines in Ado-Ekiti, Ekiti State, Nigeria

open access: yesJournal of Applied Sciences and Environmental Management, 2023
Coronavirus disease 2019 (COVID-19) manifests itself in a variety of ways, implying a wide range of host autoimmune responses which could lead to disseminated intravascular coagulation.
O. O. Odewusi   +6 more
doaj   +1 more source

Study on Anticardiolipin Antibodies in Women With Recurrent Abortion in Duhok Province, Kurdistan Region, Iraq

open access: yesActa Medica Iranica, 2020
Recurrent abortion is a worldwide issue. Anticardiolipin antibodies (ACA) are found to be among the most important factors related to recurrent spontaneous early pregnancy loss.
Ibrahim A Naqid   +4 more
doaj   +1 more source

Prevalence of anticardiolipin antibody IgM and IgG in women with recurrent abortions in Kirkuk city

open access: yesNTU Journal of Pure Sciences, 2023
Toxoplasma gondii, a parasite that can produce a wide range of clinical symptoms in humans, is the source of the zoonotic infection known as Toxoplasmosis.
Muna Aziz, Abeer Ali, Mohammed Hameed
doaj   +1 more source

Antiphospholipid Antibodies in Patients with Type 2 Diabetes Mellitus [PDF]

open access: yesAnnals of the College of Medicine Mosul, 2020
Patients with diabetes mellitus type 2 have a greater risk of accelerated atherosclerosis. Antiphospholipid antibodies(aPL)are associated with greater risk for thrombosis.
Nada Hasso, Ahmed Hussain, Ali Fatheel
doaj   +1 more source

Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification [PDF]

open access: yes, 2019
Background: Anticardiolipin (aCL) and anti-beta 2 glycoprotein I (a beta 2GPI) immunoglobulin (Ig) G/IgM antibodies are 2 of the 3 laboratory criteria for classification of antiphospholipid syndrome (APS).
de Laat, Bas   +4 more
core   +3 more sources

SARS-CoV-2 and Anti-Cardiolipin Antibodies

open access: yesClinical Medicine Insights: Case Reports, 2020
The current COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to distinct diagnostic and management challenges for front-line healthcare workers. The risk of excessive coagulation activation leading to a
Mazen Jizzini, Mohsin Shah, Kehua Zhou
doaj   +1 more source

Anticardiolipin antibodies in pathogenesis of infertility [PDF]

open access: yesVojnosanitetski Pregled, 2010
Background/Aim. Antiphospholipid syndrome (APS) is an autoimmune disorder clinically characterized by arterial or venous thrombosis and/or specific obstetric complications and presence of antiphospholipid antibodies (aPL) in the serum.
Lončar Dragan
doaj   +1 more source

Home - About - Disclaimer - Privacy